Experienced Director, Clinical Operations with a strong track record in strategic program leadership. I’ve successfully managed international and domestic clinical trials, consistently delivering high-quality results ahead of aggressive timelines. My expertise covers various therapeutic areas throughout the drug development life cycle, from first-in-human to post-marketing access, including investigator-initiated studies. Therapeutic areas include but are not limited to immunology, gastroenterology, urology, neurology, cardiology, oncology, and rare diseases in both adults and pediatrics.